(MENAFN Editorial) SAN DIEGO, CA / ACCESSWIRE / April 30, 2018 / Emerald Health Pharmaceuticals, Inc. (EHP), which is developing medicines based on cannabinoid science, announced today that Dr. Jim DeMesa, CEO, will participate in a panel to discuss how disease modifying treatments may …


Link to Full Article: Read Here

Pin It on Pinterest

Share This